Optimizing PEG Molecular Weight and Molar Composition for Enhanced In Vivo Pharmacokinetics of a Mixed Micellar siRNA Carrier
RNA interference (RNAi) by small interfering RNA (siRNA) possesses great promise as a therapeutic for pathologies whose etiology is related to gene overexpression. However, due to the poor pharmacokinetic properties of siRNA, it requires a carrier for in vivo intravenous delivery. Historically, nucl...
Main Author: | Miteva, Martina |
---|---|
Other Authors: | Craig L. Duvall |
Format: | Others |
Language: | en |
Published: |
VANDERBILT
2013
|
Subjects: | |
Online Access: | http://etd.library.vanderbilt.edu/available/etd-12022013-175726/ |
Similar Items
-
Immunomodulation of Tumor Associated Macrophages by Targeted, siRNA-Delivering Nanoparticles
by: Ortega, Ryan Adam
Published: (2014) -
Hydrophobic Modification of siRNA to Improve Delivery and Efficacy of RNAi Therapeutics
by: Sarett, Samantha Mara
Published: (2017) -
Tunable Delivery of siRNA from a Biodegradable Scaffold for Regenerative Medicine
by: Nelson, Christopher Edward
Published: (2014) -
Preparation of siRNA–PLGA/Fabʹ–PLGA mixed micellar system with target cell-specific recognition
by: Mai Hazekawa, et al.
Published: (2021-08-01) -
Modification and Evaluation of pH-Sensitive Multifunctional Amphiphilic lipids for siRNA Delivery
by: Hongfa, Jiang
Published: (2018)